Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSL#3 for Bone Mineral Density in Postmenopausal Women
NCT03165747Phase 2Terminated
- Sponsor
- Emory University
- Start
- Oct 2017
- Primary completion
- Mar 2019
- Modality
- Multi-strain Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of VSL#3 in postmenopausal osteoporosis, sponsored by Emory University. Started Oct 2017; status: terminated.
02
Drugs
VSL#3
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT03165747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03165747.